Literature DB >> 33552776

Disseminated Cryptococcal Disease in a Patient With Monoclonal Gammopathy of Undetermined Significance and Polycythemia Vera: A Case Report and Review of the Literature.

Muhammad Khurram Guhjjar1, Haider Ghazanfar1, Shoaib Ashraf2, Maneesh Gaddam3, Ajsza Matela3.   

Abstract

Cryptococcosis is a life-threatening opportunistic infection caused by Cryptococcus gattii and Cryptococcus neoformans. It affects both immunocompetent and immunosuppressed hosts. Disseminated cryptococcal infection is rare in immunocompetent patients, but the cryptococcal disease's neurological sequelae may be more prominent in this group. We present a case of a 58-year-old male patient with medical comorbidities of monoclonal gammopathy of undetermined significance (MGUS) and polycythemia vera. The patient presented with gradual worsening of mental status over one week. He was found to have Cryptococcus neoformans meningoencephalitis and fungemia. The patient received two weeks of liposomal amphotericin B (LAmB) and flucytosine with excellent clinical response. He was discharged on high dose fluconazole, and he returned to the hospital in one week with new-onset hemiplegia and cryptococcomas on imaging. Prolonged intravenous (IV) treatment of six weeks duration resulted in significant clinical improvement and disease-free state at two years follow-up. This article aims to stress the importance of individualized prolonged IV treatment with liposomal amphotericin B and flucytosine despite good initial response in patients with polycythemia vera and MGUS. This is the first reported case of cryptococcal disease, to the best of our knowledge, in a patient with MGUS and the third case of cryptococcal infection in patients with polycythemia vera in a non-HIV non-transplant state. Prolonged individualized IV treatment should be considered in immunocompetent patients with the above conditions, as this condition, if not adequately treated and relapses, lead to high morbidity and mortality.
Copyright © 2021, Guhjjar et al.

Entities:  

Keywords:  cryptococcal meningitis; cryptococcoma; immunocompetent; liposomal amphotericin b; monoclonal gammopathy of undetermined significance; polycythemia vera

Year:  2021        PMID: 33552776      PMCID: PMC7854019          DOI: 10.7759/cureus.12458

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  16 in total

1.  The poor prognosis of central nervous system cryptococcosis among nonimmunosuppressed patients: a call for better disease recognition and evaluation of adjuncts to antifungal therapy.

Authors:  Ismail Zafer Ecevit; Cornelius J Clancy; Ilona M Schmalfuss; M Hong Nguyen
Journal:  Clin Infect Dis       Date:  2006-04-11       Impact factor: 9.079

2.  Outcomes of central nervous system cryptococcosis vary with host immune function: results from a multi-center, prospective study.

Authors:  M Hong Nguyen; Shahid Husain; Cornelius J Clancy; James E Peacock; Chien-Ching Hung; Dimitrios P Kontoyiannis; Arthur J Morris; Christopher H Heath; Marilyn Wagener; Victor L Yu
Journal:  J Infect       Date:  2010-08-21       Impact factor: 6.072

Review 3.  Cryptococcosis.

Authors:  Eileen K Maziarz; John R Perfect
Journal:  Infect Dis Clin North Am       Date:  2016-03       Impact factor: 5.982

4.  Primary cutaneous cryptococcosis in a patient with systemic immunosuppression after liver transplantation.

Authors:  R E Hunger; B E Paredes; C Quattroppani; S Krähenbühl; L R Braathen
Journal:  Dermatology       Date:  2000       Impact factor: 5.366

Review 5.  Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome.

Authors:  D H Mitchell; T C Sorrell; A M Allworth; C H Heath; A R McGregor; K Papanaoum; M J Richards; T Gottlieb
Journal:  Clin Infect Dis       Date:  1995-03       Impact factor: 9.079

6.  Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

Authors:  John R Perfect; William E Dismukes; Francoise Dromer; David L Goldman; John R Graybill; Richard J Hamill; Thomas S Harrison; Robert A Larsen; Olivier Lortholary; Minh-Hong Nguyen; Peter G Pappas; William G Powderly; Nina Singh; Jack D Sobel; Tania C Sorrell
Journal:  Clin Infect Dis       Date:  2010-02-01       Impact factor: 9.079

7.  Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City.

Authors:  B P Currie; A Casadevall
Journal:  Clin Infect Dis       Date:  1994-12       Impact factor: 9.079

8.  Comparison and temporal trends of three groups with cryptococcosis: HIV-infected, solid organ transplant, and HIV-negative/non-transplant.

Authors:  Emily W Bratton; Nada El Husseini; Cody A Chastain; Michael S Lee; Charles Poole; Til Stürmer; Jonathan J Juliano; David J Weber; John R Perfect
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

9.  Predictors of mortality and differences in clinical features among patients with Cryptococcosis according to immune status.

Authors:  Kyle D Brizendine; John W Baddley; Peter G Pappas
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

10.  Disseminated Cryptococcal Disease in Non-HIV, Nontransplant Patient.

Authors:  F AlMutawa; D Leto; Z Chagla
Journal:  Case Rep Infect Dis       Date:  2016-11-09
View more
  1 in total

Review 1.  Cerebral Cryptococcomas: A Systematic Scoping Review of Available Evidence to Facilitate Diagnosis and Treatment.

Authors:  Daniel B Chastain; Amy Rao; Armaan Yaseyyedi; Andrés F Henao-Martínez; Thomas Borges; Carlos Franco-Paredes
Journal:  Pathogens       Date:  2022-02-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.